Literature DB >> 22817117

2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients.

Takashi Akiba1, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22817117     DOI： 10.1111/j.1744-9987.2012.01078.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN： 1744-9979            Impact factor:   1.762


× No keyword cloud information.
  8 in total

1.  Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus.

Authors:  Ken Sato; Yuichi Yamazaki; Tatsuya Ohyama; Takeshi Kobayashi; Norio Horiguchi; Satoru Kakizaki; Motoyasu Kusano; Masanobu Yamada
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

2.  Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.

Authors:  Goki Suda; Mineo Kudo; Atsushi Nagasaka; Ken Furuya; Yoshiya Yamamoto; Tomoe Kobayashi; Keisuke Shinada; Miki Tateyama; Jun Konno; Yoko Tsukuda; Kazushi Yamasaki; Megumi Kimura; Machiko Umemura; Takaaki Izumi; Seiji Tsunematsu; Fumiyuki Sato; Katsumi Terashita; Masato Nakai; Hiromasa Horimoto; Takuya Sho; Mitsuteru Natsuizaka; Kenichi Morikawa; Koji Ogawa; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2016-01-14       Impact factor: 7.527

3.  Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population.

Authors:  Norio Hanafusa; Shigeru Nakai; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

Review 4.  Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.

Authors:  Goki Suda; Koji Ogawa; Megumi Kimura; Masato Nakai; Takuya Sho; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Clin Transl Hepatol       Date:  2016-12-26

Review 5.  Treatment of hepatitis C in special populations.

Authors:  Goki Suda; Koji Ogawa; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-03       Impact factor: 7.527

6.  Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

Authors:  Goki Suda; Norihiro Furusyo; Hidenori Toyoda; Yoshiiku Kawakami; Hiroki Ikeda; Michihiro Suzuki; Keiko Arataki; Nami Mori; Keiji Tsuji; Yoshio Katamura; Koichi Takaguchi; Toru Ishikawa; Kunihiko Tsuji; Noritomo Shimada; Atsushi Hiraoka; Sho Yamsaki; Masato Nakai; Takuya Sho; Kenichi Morikawa; Koji Ogawa; Mineo Kudo; Atsushi Nagasaka; Ken Furuya; Yoshiya Yamamoto; Kanji Kato; Yoshiyuki Ueno; Etsuko Iio; Yasuhito Tanaka; Masayuki Kurosaki; Takashi Kumada; Kazuaki Chayama; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2017-05-30       Impact factor: 6.772

7.  Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.

Authors:  Goki Suda; Masayuki Kurosaki; Jun Itakura; Namiki Izumi; Yoshihito Uchida; Satoshi Mochida; Chitomi Hasebe; Masami Abe; Hiroaki Haga; Yoshiyuki Ueno; Ikuto Masakane; Kazumichi Abe; Atsushi Takahashi; Hiromasa Ohira; Ken Furuya; Masaru Baba; Yoshiya Yamamoto; Tomoe Kobayashi; Atsuhiko Kawakami; Kenichi Kumagai; Katsumi Terasita; Masatsugu Ohara; Naoki Kawagishi; Machiko Umemura; Masato Nakai; Takuya Sho; Mitsuteru Natsuizaka; Kenichi Morikawa; Koji Ogawa; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-07-17       Impact factor: 6.772

8.  Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.

Authors:  Taiga Otsuka; Yasunori Kawaguchi; Toshihiko Mizuta; Yasushi Ide; Futa Koga; Takanori Kumagai; Wataru Yoshioka; Kenichiro Murayama; Osamu Rikitake; Yuji Ikeda; Iwata Ozaki
Journal:  JGH Open       Date:  2017-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.